GLP-1 Decade Reshaping
Mmëdiong Gabriel Esu@mmediong
The idea
I believe GLP-1 weight-loss drugs are a decade-long shift, not a quick trend, since adoption is still early and prices are falling. The basket spreads across drugmakers, the suppliers who make the pens and ingredients, the wholesalers and telehealth that deliver the drugs, and companies tied to how people eat and move, while keeping some cash on hand. I lean on larger, steadier names with only small stakes in riskier biotech bets, and I'd rethink this if adoption stalls or pricing pressure overwhelms the growth.
What will be bought
- These companies make and sell the weight-loss drugs, so they gain most directly as more people take them. · Eli LillyIt is the largest seller of weight-loss drugs, with its oral pill version reaching people who prefer not to inject and gaining approvals across major markets., Novo NordiskIt makes weight-loss drugs in both injectable and pill forms, capturing demand from both delivery methods as the market expands., AmgenIt is developing a weight-loss drug dosed once monthly, offering an alternative for patients who prefer less frequent dosing than weekly or daily options., Viking TherapeuticsIt is a small biotech company advancing an obesity pill through late-stage trials, representing a smaller bet on a new entrant in weight-loss drugs., Structure TherapeuticsIt is developing a potentially inexpensive weight-loss pill, a small speculative position on a drug that could compete if pills dominate over injections.33%
- Every dose needs a pen, a vial or factory capacity, and these suppliers get paid no matter which drug wins. · West Pharmaceutical ServicesIt makes the stoppers, seals and plungers that go into injectable weight-loss drugs, so more shots means steady demand for its components., Thermo Fisher ScientificIt manufactures drugs and supplies development labs for other companies, earning revenue as drugmakers race to expand weight-loss medicine production., Stevanato GroupIt manufactures glass vials, cartridges and pen components filled with weight-loss injections, capturing growth in injectable drug demand., Becton DickinsonIt makes syringes and delivery pen components, providing steady exposure to growth in weight-loss injections through its established supply channels.22%
- People on these drugs eat less but want more protein and exercise, which shifts spending toward these businesses. · Abbott LaboratoriesIt sells nutrition drinks and glucose monitors that people on weight-loss drugs use to maintain health while eating less food., Planet FitnessIt operates a low-cost gym chain, and people on weight-loss drugs are advised to lift weights to preserve muscle while losing fat., BellRing BrandsIt makes high-protein shakes that help people eating smaller portions still meet their daily protein needs., Vital FarmsIt sells pasture-raised eggs and butter, protein-rich foods that appeal to people shifting toward smaller, protein-focused meals., Simply Good FoodsIt makes high-protein, low-sugar snacks under brands like Quest and Atkins, appealing to people reducing overall snack consumption while maintaining protein intake.22%
- Wholesalers and telehealth companies handle every prescription, so more patients means more volume through them. · McKessonIt distributes weight-loss drugs from manufacturers to pharmacies, and these medications are among the highest-volume prescriptions flowing through its system., CencoraIt specializes in distributing specialty and high-cost drugs, and rising weight-loss prescriptions add significant volume to its business., Hims & Hers HealthIt sells weight-loss care online at cash prices that have become affordable, expanding internationally to reach more direct-to-consumer patients.15%
- Cash8%